Crossref
26-A-17885-ACC ASSESSING CARDIOVASCULAR HEALTH OF TRANSGENDER ADULTS RECEIVING GENDER AFFIRMING HORMONE THERAPY
JACC · 2026-04 · 87 (13) · A253-A254
DOI: 10.1016/j.jacc.2026.02.625 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Lauren Stucky und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Stucky, L., Williams, A., Abe-Nornes, F., Weatherly, T., Sobol, T., Keaster, A., Davis, M., Adesanya, T. A., & Saigal, T. (2026). 26-A-17885-ACC ASSESSING CARDIOVASCULAR HEALTH OF TRANSGENDER ADULTS RECEIVING GENDER AFFIRMING HORMONE THERAPY. JACC, 87(13), A253-A254. https://doi.org/10.1016/j.jacc.2026.02.625
Vancouver
Stucky L, Williams A, Abe-Nornes F, Weatherly T, Sobol T, Keaster A, et al. 26-A-17885-ACC ASSESSING CARDIOVASCULAR HEALTH OF TRANSGENDER ADULTS RECEIVING GENDER AFFIRMING HORMONE THERAPY. JACC. 2026;87(13):A253-A254. doi:10.1016/j.jacc.2026.02.625
BibTeX
@article{Stucky2026,
author = {Stucky, Lauren and Williams, Amaris and Abe-Nornes, Fumiya and Weatherly, Taylor and Sobol, Trevor and Keaster, Andrew and Davis, Melissa and Adesanya, T.M. Ayodele and Saigal, Taru},
title = {26-A-17885-ACC ASSESSING CARDIOVASCULAR HEALTH OF TRANSGENDER ADULTS RECEIVING GENDER AFFIRMING HORMONE THERAPY},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A253--A254},
doi = {10.1016/j.jacc.2026.02.625}
}
EUVIMED